Solitary fibrous tumor/hemangiopericytoma treated with temozolomide plus bevacizumab: a report of four cases and literature review

Solitary fibrous tumor/hemangiopericytoma (SFT/HPC) is a rare tumor derived from mesenchymal tissue. Although standard chemotherapy for SHT/HPC has not been established, temozolomide plus bevacizumab (TMZ+Bev) therapy for SFT/HPC has been reported. The effectiveness and safety of TMZ+Bev (temozolomi...

Descripción completa

Detalles Bibliográficos
Autores principales: Maeda, Osamu, Ohka, Fumiharu, Maesawa, Satoshi, Matsuoka, Ayumu, Shimokata, Tomoya, Mitsuma, Ayako, Urakawa, Hiroshi, Nakamura, Shota, Shimoyama, Yoshie, Nakaguro, Masato, Wakabayashi, Toshihiko, Ando, Yuichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nagoya University 2020
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719452/
https://www.ncbi.nlm.nih.gov/pubmed/33311794
http://dx.doi.org/10.18999/nagjms.82.4.631

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719452/
https://www.ncbi.nlm.nih.gov/pubmed/33311794
http://dx.doi.org/10.18999/nagjms.82.4.631

Ejemplares similares